Related News

Home » Business

BI seeks local partners to life market share

GERMAN pharmaceutical company Boehringer Ingelheim said it is seeking more partnership with local pharmaceutical companies to lift its market share in the consumer health sector, a company senior executive said yesterday.

The company yesterday co-launched an anti-constipation traditional Chinese non-prescription drug DulcoTong through collaboration with Henan-based Furen Medicines Group. The new product will be a compliment to Boehringer Ingelheim's existing Duocolax tablet and also marks the first time the German company owns a proprietary brand and officially enters the traditional Chinese medicine market. 

Boehringer Ingelheim will oversee the marketing and distribution of DulcoTong in China's mainland and Furen will be responsible for the production.

Currently consumer healthcare and over-the-counter drugs(OTC) accounts for 11 percent of Boehringer Ingelheim's overall sales. "We're actively seeking partnerships or potential acquisition target to lift its foothold in the OTC segment," said president and chief executive officer of Boehringer Ingelheim China David Preston. 




 

Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend